The use of antiretrovirals in pregnant women is mandatory to suppress HIV replication and prevent mother-to-child vertical transmission, and some drugs are available to compound such therapeutic regimens. Infectious disease specialists and obstetricians have to work together with the aim to diminish the teratogenic effects of each drug and to protect the fetus from the virus. Herein, the most popular antiretroviral drugs are discussed, regarding their mechanism of action, adverse events and safety of use in pregnancy.
About this chapter
Cite this chapter as:Igor Thiago Queiroz, Themis Rocha Souza, Juliana Mendonça Freire, Alexandre Estevam Montenegro Diniz, Matheus de Araújo Duda ;
Anti-Infective Agents for HIV in Pregnancy, Frontiers in Anti-infective Agents Pregnancy and Anti-Infective Agents (2020) 4: 110. https://doi.org/10.2174/9789811479595120040008
Bentham Science Publisher